K. V. Levandowska. IMPROVING THE USE OF MYOCARDIAL CYTOPROTECTORS AS A METABOLIC THERAPY OF PATIENTS WITH DECOMPENSATED HEART FAILURE IN THE EARLY AND LATE POST-INFARCE PERIOD. pulse [Internet]. 2022 Dec. 28 [cited 2025 Dec. 8];(18 (66):69-83. Available from: https://pvntsh.nung.edu.ua/index.php/pulse/article/view/1858